- Home
- AMOD vs TURN Comparison
AMOD vs TURN Comparison
Compare AMOD & TURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMOD
- TURN
- Stock Information
- Founded
- AMOD 2014
- TURN 1981
- Country
- AMOD United States
- TURN United States
- Employees
- AMOD N/A
- TURN N/A
- Industry
- AMOD
- TURN Finance/Investors Services
- Sector
- AMOD
- TURN Finance
- Exchange
- AMOD NYSE
- TURN Nasdaq
- Market Cap
- AMOD 42.7M
- TURN 35.4M
- IPO Year
- AMOD N/A
- TURN N/A
- Fundamental
- Price
- AMOD $1.89
- TURN $3.71
- Analyst Decision
- AMOD
- TURN
- Analyst Count
- AMOD 0
- TURN 0
- Target Price
- AMOD N/A
- TURN N/A
- AVG Volume (30 Days)
- AMOD 110.6K
- TURN 32.1K
- Earning Date
- AMOD 01-01-0001
- TURN 02-18-2025
- Dividend Yield
- AMOD N/A
- TURN N/A
- EPS Growth
- AMOD N/A
- TURN N/A
- EPS
- AMOD N/A
- TURN N/A
- Revenue
- AMOD N/A
- TURN $129,297.00
- Revenue This Year
- AMOD N/A
- TURN N/A
- Revenue Next Year
- AMOD N/A
- TURN N/A
- P/E Ratio
- AMOD N/A
- TURN N/A
- Revenue Growth
- AMOD N/A
- TURN 6.32
- 52 Week Low
- AMOD $1.70
- TURN $3.12
- 52 Week High
- AMOD $13.49
- TURN $4.47
- Technical
- Relative Strength Index (RSI)
- AMOD N/A
- TURN 52.05
- Support Level
- AMOD N/A
- TURN $3.55
- Resistance Level
- AMOD N/A
- TURN $3.72
- Average True Range (ATR)
- AMOD 0.00
- TURN 0.12
- MACD
- AMOD 0.00
- TURN -0.01
- Stochastic Oscillator
- AMOD 0.00
- TURN 68.68
About AMOD ALPHA MODUS HOLDINGS INC
Alpha Modus Holdings Inc is a technology company with a core focus on artificial intelligence in retail. It is engaged in creating, developing and licensing data-driven technologies to enhance consumers' in-store digital experience at the point of decision.
About TURN 180 Degree Capital Corp.
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.